Moreover, the ability of extract to target specific pathways, namely ERK1/2 and AKT/mTOR, was also identified in a mouse model of tumor angiogenesis [41] and in acute myeloid leukemia (AML) xenografts [43]. This evidence concerns the gene AKT1 and neoplasm.